How new hepatitis C drugs could tackle liver cancer, too
- Written by Maryam Alavi, Research Associate, The Kirby Institute, UNSW
How to cut rates of liver cancer? Reducing hepatitis C rates would be a good start.from www.shutterstock.comWider availability of newer hepatitis C drugs may not only lead to fewer cases of this blood-borne disease, but may also slow the rise in related liver cancer.
But these so-called direct acting antiviral drugs have not been widely available...
